Tag: NLRP3 inflammasome inhibitor
Zydus Lifesciences completes enrolment for clinical trial of Usnoflast
Zydus Lifesciences announced the completion of enrolment for its Phase II clinical trial of Usnoflast (ZYIL1), an oral…
Zydus Lifesciences announced the completion of enrolment for its Phase II clinical trial of Usnoflast (ZYIL1), an oral…